126 results on '"Marotta, Serena"'
Search Results
2. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
3. Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy
4. Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
5. Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs
6. Eltrombopag for post-transplant cytopenias due to poor graft function
7. Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide
8. Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.
9. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future
10. Complement Biomarkers for Tracking Breakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Last-Generation Complement Inhibitors
11. Acute immune toxicity during anti‐thymocyte globulin: Thatʼs CARPA!
12. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
13. It's a bad year for ticks, and they're no longer just a rural menace
14. Can antibodies from breast milk help fight COVID-19?
15. 'Our souls are numb'
16. MICHAEL J. FOX IS BORN; MOMENT IN TIME JUNE 9, 1961
17. The fight to bring back the mottled duskywing
18. Scientists call for an end to 'hygiene theatre'
19. No vaccine-menstruation link, experts say
20. Many still eager for AstraZeneca vaccine despite mixed messages
21. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations
22. Letermovir Prophylaxis For Cytomegalovirus Reactivation in Allogeneic Stem Cell Transplantation: A Multicenter Italian Real-world Experience
23. Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
24. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
25. Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT
26. Novel anti-complement agents for PNH:from eculizumab to complement inhibition 2.0
27. Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learned
28. Eltrombopag for Prolonged Post-Transplant Hyporigenerative Cytopenias
29. Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
30. Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learned
31. Acute immune toxicity during anti-thymocyte globulin: That's CARPA!
32. Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions
33. CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT
34. ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY
35. Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study
36. Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions
37. Aplastic Anemia in the Context of Hemolytic Paroxysmal Nocturnal Hemoglobinuria: Feasibility of Antibody-Based Intensive Immunosuppression during Eculizumab Treatment
38. Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions.
39. The Natural History of Fanconi Anemia: A Report from the Italian Fanconi Anemia Registry (RIAF)
40. Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients
41. Solitary plasmacytoma of the jaw
42. Circulating Megakaryocyte-Derived Cells Detected by Flow Cytometry As Marker of Aggressive Neoplasms of Megakaryocytic Lineage in Acute Megakaryoblastic Leukemia and Allied Malignancies Presenting As Primary Myelofibrosis
43. Endothelial complications after hematopoietic stem cell transplantation.
44. Solitary plasmacytoma of the jaw.
45. NON-FIRST DEGREE RELATIVE DONOR AND THE OUTCOME OF PATIENTS RECEIVING T CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
46. Soluzioni numeriche alla ricostruzione tomografica cone-beam per tessuti molli
47. Alcuni metodi matriciali per lo Spectral Clustering
48. Soluzioni numeriche alla ricostruzione tomografica cone-beam per tessuti molli
49. Alcuni metodi matriciali per lo Spectral Clustering
50. Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.